Our range of medicines is constantly adapted to the current market shortages and the needs of Polish hospitals.
Since 2019, thanks to our activity on international markets, we have imported over 1 million packages of medicines.

The active substances whose limited availability has been particularly problematic for Polish hospitals include basic antibiotics such as: piperacillin with tazobactam or amoxicillin + clavulanic acid (particularly in demand during the pandemic), as well as dobutamine, thiopental, injectable vitamins, streptomycin, calcium gluconate and cytostatic drugs such as thalidomide or cytarabine, the shortages of which took the hospital market by surprise.

We offer a portfolio of imported drugs for which we have obtained the relevant approvals from the Ministry of Health. At the same time, we guarantee competitive prices on the market.